|
2023
|
Invention
|
Novel selective inhibitors of lysyl oxidases. The present invention relates to novel fluoroallyla... |
|
|
Invention
|
Lysyl oxidase inhibitors for treating myeloid malignancies.
Lysyl oxidase (LOX) inhibitors, lysy... |
|
2021
|
Invention
|
Haloallylamine dual amine oxidase inhibitors.
The present invention relates to novel compounds w... |
|
|
Invention
|
Haloallylamine dual amine oxidase inhibitors. The present invention relates to novel compounds wh... |
|
|
Invention
|
Bioprobes for lysyl oxidases and uses thereof.
The present invention relates to novel bioprobes ... |
|
|
Invention
|
Bioprobes for lysyl oxidases and uses thereof. The present invention relates to novel bioprobes w... |
|
2020
|
Invention
|
Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, a... |
|
2019
|
Invention
|
Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof. The present inve... |
|
2018
|
Invention
|
Haloallylamine pyrazole derivative inhibitors of lysyl oxidases and uses thereof.
The present in... |
|
|
Invention
|
Haloallylamine pyrazole derivative inhibitors of lysyl oxidases and uses thereof. The present inv... |
|
2017
|
Invention
|
Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof. The... |
|
|
Invention
|
Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof. The... |
|
2016
|
Invention
|
Substituted 3-haloallylamine inhibitors of ssao and uses thereof. The present invention is relate... |
|
2013
|
Invention
|
Substituted 3-haloallylamine inhibitors of assao and uses thereof. The preparation and pharmaceut... |
|
2012
|
Invention
|
Improvements relating to delivery devices. A delivery device (100,200) is disclosed, which compri... |
|
|
Invention
|
Medicament delivery device having improved powder emission and deagglomeration. A delivery device... |
|
|
Invention
|
A delivery device comprising a free-standing container. A delivery device comprises a free-standi... |
|
|
Invention
|
Oligonucleotide inhibitors with chimeric backbone and 2-amino-2'-deoxyadenosine.
There is provid... |
|
|
Invention
|
Oligonucleotide inhibitors with chimeric backbone and 2-amino-2'-deoxyadenosine. There is provide... |
|
2011
|
Invention
|
Antisense oligonucleotides for treating allergy and neoplastic cell proliferation. Antisense olig... |
|
2010
|
Invention
|
Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders. Methods of u... |
|
2008
|
Invention
|
Haloallylamine inhibitors of ssao/vap-1 and uses therefor. The present invention is related to th... |
|
|
G/S
|
Pharmaceutical preparations to treat and prevent diseases and disorders associated with the respi... |
|
|
G/S
|
Pharmaceutical preparations and substances; pharmaceutical
reagents and antibodies, chemical rea... |
|
2007
|
G/S
|
Pharmaceutical preparations. |
|
2006
|
G/S
|
Pharmaceutical preparations and substances; pharmaceutical reagents and antibodies, chemical reag... |
|
|
G/S
|
Pharmaceutical preparations to aid in the diagnosis and management of asthma; pharmaceutical prep... |
|
|
G/S
|
Diagnostic pharmaceutical preparations for medical purposes in evaluating and managing asthma; di... |
|
2005
|
G/S
|
Inhalable pharmaceutical products in powder or capsule form for the management (namely assesment... |
|
2004
|
Invention
|
Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation. The pr... |
|
2002
|
Invention
|
Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammal... |
|
2001
|
Invention
|
Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell prolife... |
